Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The approval follows a positive finding in the pivotal IRAKLIA Phase III study, ...
Inclusion based on S&P Global sustainability assessment covering global companie...
Chris Nicholson explores the parallel between the FIFA World Cup tournament and ...
Acquisition to expand Aurobindo USA's portfolio of complex generics and U.S. man...
The data was strong enough for Intellia to continue the rolling Biologics Licens...
Embracing Wellness Beyond Healthcare Every year on June 21, the world comes toge...
Eddie Scher, a defining figure in UK implant dentistry and former ADI president,...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...
Author Vijay Martis explains how Cipla's business model, strategy and purpose s...
With skill mix being hailed as the new way of working for the NHS, does dental t...
This week, I covered the story of Casey Harrell—a man with ALS who is “the first...
This article was updated on June 19, 2026, by Rebecca Lapides to reflect the mos...
The deal value comprises an upfront payment and further payments tied to the ach...
The partnership will bring together Voro Therapeutics’ tumour-activated biologic...
Two-day conference to focus on regulatory writing, AI governance, patient-centri...
Oliver Smart and Cat McLennan discuss how MiSmile Treatment Planning Services he...
